Trial intelligence / Profile preview

Innovative approaches for cocaine pharmacotherapy using fMRI: varenicline

2008-001786-28Phase 4Active

Sponsor
Amsterdam UMC
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of varenicline in cocaine use disorder (CUD), sponsored by Amsterdam UMC. Primary endpoint: Therapeutic effect of varenicline on cocaine addiction assessed by fMRI and neuropsychological tests. Started Jun 2008; status: active.

02

Drugs

varenicline
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on 2008-001786-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001786-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call